Amgen out of development pact. (The Digest).Praecis Pharmaceuticals will pay Amgen Inc. $13 million to wrap up the drawn-out Adj. 1. drawn-out - relatively long in duration; tediously protracted; "a drawn-out argument"; "an extended discussion"; "a lengthy visit from her mother-in-law"; "a prolonged and bitter struggle"; "protracted negotiations" development of a prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. drug. Last fall, Amgen dropped out of an agreement with the Massachusetts-based firm. The Food and Drug Administration had earlier rejected Praecis' application to market PIenaxis, a prostate cancer drug that was developed in conjunction with Amgen. In a similar vein, Thousand Oaks-based Amgen ended a licensing agreement with Baltimore-based Guilford Pharmaceuticals in September. The second phase of clinical trials with Gilford's Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. drug was not fruitful fruit·ful adj. 1. a. Producing fruit. b. Conducive to productivity; causing to bear in abundance: fruitful soil. 2. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion